Category
Enalapril
CAS Number
76391-34-9
Molecular Formula
C₂₂H₃₂N₂O₅
Molecular Weight
404.5 g/mol
Synonym

(2S)-1-[(2S)-2-[[(1S)-1-(butoxycarbonyl)-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic acid ; ((S)-1-butoxy-1-oxo-4-phenylbutan-2-yl)-L-alanyl-L-proline ; Enalapril Butyl Ester Analog ; Enalapril EP Impurity F;Enalapril EP Impurity F;L-Proline,1-[N-[1-(butoxycarbonyl)-3-phenylpropyl]-L-alanyl]-,(S)-;(2S)-1-[(2S)-2-[[(1S)-1-(butoxycarbonyl)-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic acid

Keywords
Amines
Intermediates
Fine Chemicals
Impurities
Heterocycles
Chiral standards
Pharmaceutical Standards
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Enalapril EP Impurity F is a known process-related or degradation impurity of Enalapril as defined in the European Pharmacopoeia (EP). It forms during synthesis or storage and is structurally related to enalapril but may have altered chemical groups. Like other controlled impurities, it is monitored to ensure the drug’s safety, quality, and efficacy.